Drug & intervention

fingolimod 0.5 MG

RxCUI 1012893

Clinical trials4

Recruiting0

Related conditions3

Synonyms1

RxNorm ingredient and formulation relationships

Source-verified product relationships. Every strength, delivery form and RxCUI remains a separate clinical concept.

Loading RxNorm relationships…

Clinical trials

4 shown

Fingolimod Effect on Cytokine and Chemokine LevelsNCT02373098 · 2015-03-31

Long-term Efficacy and Safety of Fingolimod (FTY720) in Patients With Relapsing-remitting Multiple SclerosisNCT00662649 · 2008-02-01

Efficacy and Safety of Fingolimod in Patients With Relapsing-remitting Multiple Sclerosis With Optional Extension PhaseNCT00340834 · 2006-05-01

Efficacy and Safety of Fingolimod in Patients With Relapsing-remitting Multiple SclerosisNCT00289978 · 2006-01-01

Conditions being studied

Multiple Sclerosis2 Relapsing Remitting Multiple Sclerosis1 Relapsing-remitting Multiple Sclerosis1

Research locations

AthensGreece3 BerlinGermany3 DüsseldorfGermany3 HamburgGermany3 IstanbulTurkey (Türkiye)3 MünchenGermany3 TübingenGermany3 HaifaIsrael2 Kazan'Russia2 LeipzigGermany2 LodzPoland2 LondonUnited Kingdom2

Leading sponsors

Novartis3 Novartis Pharmaceuticals1

Drug identity and terminology: RxNorm. Trial relationships: ClinicalTrials.gov.